Nr 546 week 6 Study guides, Class notes & Summaries

NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulations), narcolepsy. Off-label for treatmentresistant depression. Enhancement DA and NE in certain areas of the brain (dorsolateral prefrontal cortex, medial prefrontal cortex). Primary target symptoms: concentration, attention span, motor hyperactivity,...

NR 546 | NR546 Week 6 | Psychopharmacology for the Psychiatric | Answered and Graded A+ | 2024 Guide NR 546 | NR546 Week 6 | Psychopharmacology for the Psychiatric | Answered and Graded A+ | 2024 Guide

NR 546 WEEK 1 Quiz TO Week 6 Quiz with Accurate answers NR 546 WEEK 1 Quiz What should the PMHNP consider when prescribing chemical restraints? --*correct answer*---allergy status -prior med hx for adverse drug reactions r/t the meds ordered in the chemical restraint -state regulations regarding chemical restrains must be reviewed How does reviewing the genetic makeup of a client help guide the PMHNP in selecting medication for clients? --*correct answer*---Genetic testing can assist b...

Midterm Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review |Weeks 1-4 | Questions and Verified Answers| 100% Correct- Chamberlain QUESTION Haloperidol, ziprasidone, and olanzapine Answer: increased risk of CVA, cognitive decline, and death in older adults with dementia and dementia related psychosis QUESTION aripiprazole black box warning Answer: medication with increased risk of suicide in...

NR 546 Week 6 Case Study 2023/2024 | 100% Correct Verified NR 546 Week 6 Case Study 2023/2024 | 100% Correct Verified

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+ Drug Name Indication Neurotransmitter(s) Affected Target Symptoms Half-life (T1/2), Metabolism (CYP 450 enzyme) Notable Side Effects (link to NT or affected brain circuit) Initial Dosing Considerations Specific lifespan considerations (age, pregnancy, breastfeeding) Buprenorphine (Subutex) Indication: • Maintenance treatment of opioid dep...

NR 546 Week 6 Addiction Medications Table. Maintenance treatment of opioid dependence (sublingual)  Maintenance treatment of opioid dependence in patients who have achieved and sustained prolonged clinical stability on low-to-moderate doses (no more than 8 mg) of a transmucosal buprenorphine- containing product (implant)  Moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal buprenorphine-containing product, followed by dose ...

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+